메뉴 건너뛰기




Volumn 101, Issue 2, 2006, Pages 243-247

Third-line rescue therapy with levofloxacin after two H. pylori treatment failures

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; CARBON 13; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE BISMUTH CITRATE; TETRACYCLINE;

EID: 33644898547     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00457.x     Document Type: Article
Times cited : (100)

References (24)
  • 1
    • 0035999136 scopus 로고    scopus 로고
    • Helicobacter pylori'rescue' regimen when proton pump inhibitor-based triple therapies fail
    • Gisbert JP Pajares JM Helicobacter pylori'rescue' regimen when proton pump inhibitor-based triple therapies fail Aliment Pharmacol Ther 2002 16 1047 57
    • (2002) Aliment Pharmacol Ther , vol.16 , pp. 1047-57
    • Gisbert, J.P.1    Pajares, J.M.2
  • 2
    • 0036171551 scopus 로고    scopus 로고
    • Current concepts in the management of Helicobacter pylori infection - The Maastricht 2-2000 consensus report
    • Malfertheiner P Megraud F O'Morain C et al Current concepts in the management of Helicobacter pylori infection - The Maastricht 2-2000 consensus report Aliment Pharmacol Ther 2002 16 167 80
    • (2002) Aliment Pharmacol Ther , vol.16 , pp. 167-80
    • Malfertheiner, P.1    Megraud, F.2    O'Morain, C.3    Al, E.4
  • 3
    • 25444490967 scopus 로고    scopus 로고
    • Review article: Helicobacter pylori"rescue" therapy after failure of two eradication treatments
    • Gisbert JP Pajares JM Review article: Helicobacter pylori" rescue" therapy after failure of two eradication treatments Helicobacter 2005 10 363 72
    • (2005) Helicobacter , vol.10 , pp. 363-72
    • Gisbert, J.P.1    Pajares, J.M.2
  • 4
    • 0142056161 scopus 로고    scopus 로고
    • A clinical practice viewpoint: To culture or not to culture Helicobacter pylori¿
    • Zullo A Hassan C Lorenzetti R et al A clinical practice viewpoint: To culture or not to culture Helicobacter pylori¿ Dig Liver Dis 2003 35 357 61
    • (2003) Dig Liver Dis , vol.35 , pp. 357-61
    • Zullo, A.1    Hassan, C.2    Lorenzetti, R.3    Al, E.4
  • 5
    • 0347989421 scopus 로고    scopus 로고
    • Levofloxacin: A review of its use in the treatment of bacterial infections in the United States
    • Croom KF Goa KL Levofloxacin: A review of its use in the treatment of bacterial infections in the United States Drugs 2003 63 2769 802
    • (2003) Drugs , vol.63 , pp. 2769-802
    • Croom, K.F.1    Goa, K.L.2
  • 6
    • 1342281526 scopus 로고    scopus 로고
    • The TETRA study: A prospective evaluation of Helicobacter pylori'test-and-treat' strategy on 736 patients in clinical practice
    • Gisbert JP Badia X Roset M et al The TETRA study: A prospective evaluation of Helicobacter pylori'test-and-treat' strategy on 736 patients in clinical practice Helicobacter 2004 9 28 38
    • (2004) Helicobacter , vol.9 , pp. 28-38
    • Gisbert, J.P.1    Badia, X.2    Roset, M.3    Al, E.4
  • 7
    • 0033785715 scopus 로고    scopus 로고
    • Third line treatment for Helicobacter pylori: A prospective, culture-guided study in peptic ulcer patients
    • Gomollon F Sicilia B Ducons JA et al Third line treatment for Helicobacter pylori: A prospective, culture-guided study in peptic ulcer patients Aliment Pharmacol Ther 2000 14 1335 8
    • (2000) Aliment Pharmacol Ther , vol.14 , pp. 1335-8
    • Gomollon, F.1    Sicilia, B.2    Ducons, J.A.3    Al, E.4
  • 8
    • 4344592305 scopus 로고    scopus 로고
    • H pylori antibiotic resistance: Prevalence, importance, and advances in testing
    • Megraud F H pylori antibiotic resistance: Prevalence, importance, and advances in testing Gut 2004 53 1374 84
    • (2004) Gut , vol.53 , pp. 1374-84
    • Megraud, F.1
  • 9
    • 0033900316 scopus 로고    scopus 로고
    • Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones
    • Sanchez JE Saenz NG Rincon MR et al Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones J Antimicrob Chemother 2000 46 283 5
    • (2000) J Antimicrob Chemother , vol.46 , pp. 283-5
    • Sanchez, J.E.1    Saenz, N.G.2    Rincon, M.R.3    Al, E.4
  • 10
    • 0036724705 scopus 로고    scopus 로고
    • Alternative and rescue treatment regimens for Helicobacter pylori eradication
    • Xia HH Yu Wong BC et al Alternative and rescue treatment regimens for Helicobacter pylori eradication Expert Opin Pharmacother 2002 3 1301 11
    • (2002) Expert Opin Pharmacother , vol.3 , pp. 1301-11
    • Xia, H.H.1    Yu Wong, B.C.2    Al, E.3
  • 11
    • 1542574196 scopus 로고    scopus 로고
    • [laboratory and clinical study of levofloxacin against Helicobacter pylori]
    • Zou J Yang ZX Qin ZM [Laboratory and clinical study of levofloxacin against Helicobacter pylori] Zhonghua Yi Xue Za Zhi 2003 83 1778 81
    • (2003) Zhonghua Yi Xue Za Zhi , vol.83 , pp. 1778-81
    • Zou, J.1    Yang, Z.X.2    Qin, Z.M.3
  • 12
    • 21744463045 scopus 로고    scopus 로고
    • A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses
    • Gatta L Zullo A Perna F et al A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses Aliment Pharmacol Ther 2005 22 45 9
    • (2005) Aliment Pharmacol Ther , vol.22 , pp. 45-9
    • Gatta, L.1    Zullo, A.2    Perna, F.3    Al, E.4
  • 13
    • 0034532026 scopus 로고    scopus 로고
    • Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999)
    • Cabrita J Oleastro M Matos R et al Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999) J Antimicrob Chemother 2000 46 1029 31
    • (2000) J Antimicrob Chemother , vol.46 , pp. 1029-31
    • Cabrita, J.1    Oleastro, M.2    Matos, R.3    Al, E.4
  • 14
    • 0035992160 scopus 로고    scopus 로고
    • Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori
    • Tanaka M Isogai E Isogai H et al Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori J Antimicrob Chemother 2002 49 1039 40
    • (2002) J Antimicrob Chemother , vol.49 , pp. 1039-40
    • Tanaka, M.1    Isogai, E.2    Isogai, H.3    Al, E.4
  • 15
    • 1942459285 scopus 로고    scopus 로고
    • Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy
    • Watanabe Y Aoyama N Shirasaka D et al Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy Dig Liver Dis 2003 35 711 5
    • (2003) Dig Liver Dis , vol.35 , pp. 711-5
    • Watanabe, Y.1    Aoyama, N.2    Shirasaka, D.3    Al, E.4
  • 16
    • 9144258031 scopus 로고    scopus 로고
    • A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: A controlled trial
    • Bilardi C Dulbecco P Zentilin P et al A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: A controlled trial Clin Gastroenterol Hepatol 2004 2 997 1002
    • (2004) Clin Gastroenterol Hepatol , vol.2 , pp. 997-1002
    • Bilardi, C.1    Dulbecco, P.2    Zentilin, P.3    Al, E.4
  • 17
    • 0034853463 scopus 로고    scopus 로고
    • Helicobacter pylori therapy: First-line options and rescue regimen
    • Gisbert JP Pajares JM Helicobacter pylori therapy: First-line options and rescue regimen Dig Dis 2001 19 134 43
    • (2001) Dig Dis , vol.19 , pp. 134-43
    • Gisbert, J.P.1    Pajares, J.M.2
  • 18
    • 0142187289 scopus 로고    scopus 로고
    • Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'
    • Perri F Festa V Merla A et al Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy' Aliment Pharmacol Ther 2003 18 815 20
    • (2003) Aliment Pharmacol Ther , vol.18 , pp. 815-20
    • Perri, F.1    Festa, V.2    Merla, A.3    Al, E.4
  • 19
    • 0141539362 scopus 로고    scopus 로고
    • Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: A randomized trial
    • Nista EC Candelli M Cremonini F et al Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: A randomized trial Aliment Pharmacol Ther 2003 18 627 33
    • (2003) Aliment Pharmacol Ther , vol.18 , pp. 627-33
    • Nista, E.C.1    Candelli, M.2    Cremonini, F.3    Al, E.4
  • 20
    • 0035690210 scopus 로고    scopus 로고
    • Helicobacter pylori eradication: Do we have another ace up our sleeve¿
    • Zullo A Hassan C Lorenzetti R et al Helicobacter pylori eradication: Do we have another ace up our sleeve¿ Dig Liver Dis 2001 33 805 6
    • (2001) Dig Liver Dis , vol.33 , pp. 805-6
    • Zullo, A.1    Hassan, C.2    Lorenzetti, R.3    Al, E.4
  • 21
    • 0042809593 scopus 로고    scopus 로고
    • A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication
    • Zullo A Hassan C De Francesco V et al A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication Dig Liver Dis 2003 35 232 6
    • (2003) Dig Liver Dis , vol.35 , pp. 232-6
    • Zullo, A.1    Hassan, C.2    De Francesco, V.3    Al, E.4
  • 22
    • 20144387230 scopus 로고    scopus 로고
    • New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: A pilot study
    • Coelho LG Moretzsohn LD Vieira WL et al New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: A pilot study Aliment Pharmacol Ther 2005 21 783 7
    • (2005) Aliment Pharmacol Ther , vol.21 , pp. 783-7
    • Coelho, L.G.1    Moretzsohn, L.D.2    Vieira, W.L.3    Al, E.4
  • 23
    • 0242584411 scopus 로고    scopus 로고
    • 'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures
    • Gisbert JP Calvet X Bujanda L et al 'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures Helicobacter 2003 8 90 94
    • (2003) Helicobacter , vol.8 , pp. 90-94
    • Gisbert, J.P.1    Calvet, X.2    Bujanda, L.3    Al, E.4
  • 24
    • 0034851910 scopus 로고    scopus 로고
    • Latest industry information on the safety profile of levofloxacin in the US
    • discussion 44-8
    • Kahn JB Latest industry information on the safety profile of levofloxacin in the US Chemotherapy 2001 47 suppl 3 32 7 discussion 44-8
    • (2001) Chemotherapy , vol.47 , Issue.3 SUPPL. , pp. 32-7
    • Kahn, J.B.X.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.